The rivaroxaban-adjusted normalized ratio: Use of the prothrombin time to monitor the therapeutic effect of rivaroxaban.

CONCLUSION: Using a rivaroxaban-specific NR effectively minimises inter-thromboplastin variability. By utilizing NR-rivaroxaban, the standardized prothrombin time results could be rapidly obtained, especially useful in standardising the therapeutic effect of rivaroxaban. PMID: 30967043 [PubMed - as supplied by publisher]
Source: British Journal of Biomedical Science - Category: Laboratory Medicine Tags: Br J Biomed Sci Source Type: research